Form 4: Thermopylae Holdings Ltd. Reports Charitable Donation of AbCellera Biologics Inc. Shares

Sentiment:

SEC Form 4 Filing


Thermopylae Holdings Ltd., a 10% owner of AbCellera Biologics Inc., reported a charitable donation of 286,000 common shares.

Summary

  • Thermopylae Holdings Ltd., a significant shareholder of AbCellera Biologics Inc., has filed a Form 4 with the SEC.
  • The filing discloses a charitable donation of 286,000 common shares of AbCellera Biologics Inc. by Thermopylae Holdings Ltd.
  • The transaction occurred on December 4, 2024.
  • Following the donation, Thermopylae Holdings Ltd. beneficially owns 55,800,009 common shares of AbCellera Biologics Inc.

Sentiment

Score: 5

Explanation: The document is a neutral disclosure of a transaction, not indicative of positive or negative sentiment.

Industry Context

This filing is a routine disclosure of a significant shareholder's transaction and does not indicate any specific trend in the biotechnology industry.

Comparison to Industry Standards

  • Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and major shareholders.
  • The donation of shares is not unusual, and the size of the donation is not significant relative to the total shares owned by Thermopylae Holdings Ltd.

Stakeholder Impact

  • The donation of shares has a minor impact on the total outstanding shares of AbCellera Biologics Inc.

Key Dates

DateDescription
12/04/2024Date of the charitable donation of AbCellera Biologics Inc. shares.
12/05/2024Date of signature for the Form 4 filing.

Keywords

AbCellera Biologics Inc., Thermopylae Holdings Ltd., charitable donation, Form 4, SEC filing, shareholder, common shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.